8 Recruiting Studies Using Corticosteroids
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Corticosteroids
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
📍 Novartis Investigative Site — Camperdown, New South Wales
Follicular Lymphoma (FL)
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD
📍 Banner MD Anderson — Phoenix, Arizona
Graft Versus Host Disease, Acute
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)
📍 Cedars-Sinai Medical Center- Site Number : 8400100 — Los Angeles, California
Transplant Rejection
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
📍 Mayo Clinic Hospital — Phoenix, Arizona
Chronic Graft-versus-host-disease
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
📍 Yuma Regional Medical Center — Yuma, Arizona
Primary Immune Thrombocytopenia (ITP)
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Hairy Cell Leukemia
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
📍 Local Institution - 0042 — Birmingham, Alabama
Renal Allograft Recipients
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
📍 University of Alabama Birmingham — Birmingham, Alabama
Chronic Graft-versus-host-disease
View Study & Checklist ➔